Prestige Consumer Healthcare INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Ariel Investments, LLC has increased its beneficial ownership of Prestige Consumer Healthcare Inc. common stock to 10.3%, acquiring 4,868,711 shares.
NYSE
Vanguard Capital Management has reported beneficial ownership of 2,454,974 shares, representing 5.18% of the outstanding common stock of Prestige Consumer Healthcare Inc.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.97% of Prestige Consumer Healthcare Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group filed an amended Schedule 13G for Prestige Consumer Healthcare Inc., reporting 0% beneficial ownership following an internal realignment.
NYSE
Ariel Investments, LLC has disclosed an 8.5% beneficial ownership stake in Prestige Consumer Healthcare Inc., holding over 4.1 million shares.
NYSE
Ariel Investments, LLC has reported a 7.3% beneficial ownership stake in Prestige Consumer Healthcare I, holding 3,594,959 shares of common stock.
NYSE
Ariel Investments, LLC has filed an amended Schedule 13G, disclosing a 4.5% beneficial ownership stake in Prestige Consumer Healthcare I's common stock.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Prestige Consumer Healthcare, Disclosing 15.2% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, reporting a 15.2% beneficial ownership stake in Prestige Consumer Healthcare Inc. as of March 31, 2025.
NYSE
Macquarie Group Limited and its subsidiaries have filed an amended Schedule 13G, revealing a passive beneficial ownership of 4.67% in Prestige Consumer Healthcare Inc. as of December 31, 2024.
NYSE
Dimensional Fund Advisors LP reports beneficial ownership of 5.9% of Prestige Consumer Healthcare Inc's common stock as of December 31, 2024.